Ascentage Pharma Group International (AAPG) Retained Earnings: 2023-2024
Historic Retained Earnings for Ascentage Pharma Group International (AAPG) over the last 2 years, with Dec 2024 value amounting to -$790.6 million.
- Ascentage Pharma Group International's Retained Earnings fell 6.09% to -$790.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$790.6 million, marking a year-over-year decrease of 6.09%. This contributed to the annual value of -$790.6 million for FY2024, which is 4.13% down from last year.
- Per Ascentage Pharma Group International's latest filing, its Retained Earnings stood at -$790.6 million for FY2024, which was down 4.13% from -$759.2 million recorded in FY2023.
- Ascentage Pharma Group International's Retained Earnings' 5-year high stood at -$759.2 million during FY2023, with a 5-year trough of -$790.6 million in FY2024.
- Its 2-year average for Retained Earnings is -$774.9 million, with a median of -$774.9 million in 2024.
- Data for Ascentage Pharma Group International's Retained Earnings shows a maximum YoY decreased of 4.13% (in 2024) over the last 5 years.
- Ascentage Pharma Group International's Retained Earnings (Yearly) stood at -$759.2 million in 2023, then declined by 4.13% to -$790.6 million in 2024.